Faron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Below 50-Day Moving Average – Should You Sell?

Faron Pharmaceuticals Oy (LON:FARN) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 171.53 ($2.15) and traded as low as GBX 167.70 ($2.10). Faron Pharmaceuticals Oy shares last traded at GBX 167.80 ($2.10), with a volume of 3,575 shares.

Faron Pharmaceuticals Oy Price Performance

The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09. The company has a market capitalization of £175.45 million, a P/E ratio of -524.06 and a beta of 0.36. The firm’s 50-day moving average is GBX 171.53 and its 200-day moving average is GBX 167.15.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.